Skip to Content
Merck
CN
  • Synthesis and enzymatic evaluation of pyridinium-substituted uracil derivatives as novel inhibitors of thymidine phosphorylase.

Synthesis and enzymatic evaluation of pyridinium-substituted uracil derivatives as novel inhibitors of thymidine phosphorylase.

Bioorganic & medicinal chemistry (2002-01-30)
Paul E Murray, Virginia A McNally, Stacey D Lockyer, Kaye J Williams, Ian J Stratford, Mohammed Jaffar, Sally Freeman
ABSTRACT

A series of water soluble N(1)- and C(6)-substituted uracil pyridinium compounds were prepared as potential inhibitors of thymidine phosphorylase (TP). The C(6)-uracil substituted derivatives were the most active. 1-[(5-Chloro-2,4-dihydroxypyrimidin-6-yl)methyl]pyridinium chloride, was identified as the best inhibitor being 5-fold more potent than the known inhibitor, 6-amino-5-bromouracil.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
6-(Chloromethyl)uracil, 98%